A pharmaceutical team was challenged to hold a preceptorship for a group of global learners during the pandemic. By using over-time virtual engagement, the team was able to create a collaborative learning experience without scheduling challenges or the need for travel.
A medical affairs team needed a global hub that would support a number of initiatives for a rare disease program. The team established a hybrid resource center by leveraging Within3's Insights Suite and Collaboration Suite platforms to create a unified, seamless experience between periodic over-time engagements and an online information repository.
With so many ways to communicate – email, intranet, file sharing, and more – clinical operations teams need a single point of truth to ensure clinical trial stakeholders have access to the same up-to-date resources. Learn how one team created an online resource center and training hub to provide access to critical data, training materials, and even links to external systems used in day-to-day workflows.
When a medical affairs team wanted to obtain feedback from European cardiologists to define the screening process for a rare disease, they opted to use the Delphi method – a process in which experts respond to subsequent rounds of questions. The team conducted its Delphi panel on the Within3 virtual engagement platform over three over-time sessions and achieved its objective in less than a month.
Commercial teams rely on feedback from HCPs to ensure a holistic understanding of the market. Conducting this research can be complex and time-consuming, with long planning cycles and unpredictable results. How can business teams ensure consistently high-quality feedback while shortening the timeline from insight to action? In this case study, learn how a commercial team contracted a group of advisors to periodically provide rapid feedback via the Within3 platform and gained the ability to compare results across groups of prescribers and among individuals.
Getting real-world perspective from HCPs is key to designing a successful clinical study. To ensure both doctors and nurses were equally heard during the process of insight-gathering for a phase IV study, a pharmaceutical team leveraged separate virtual rooms, private questions, and other tools to ensure comprehensive feedback. Learn how the team planned and executed the advisory board meeting in just a few weeks rather than several months – and received the input needed to design a more successful trial.
When a medical affairs team needed to obtain feedback on patient pathways across a geographic region, they combined the 24/7 convenience of over-time engagement with a live webcast to establish consensus on topics discussed in the asynchronous session.
Gathering patient perspectives on educational materials is critical. In order to efficiently collect actionable feedback from a group of patients, a patient advocacy team within a leading pharmaceutical company held a two-week virtual advisory board. Patients viewed resources within the platform, which they could access 24/7 from any connected device. Read the case study to learn how patient input helped improve the educational materials.
A medical affairs team used the Within3 virtual engagement platform to get feedback on proposed training activities. As a result, the team saved weeks of time normally spent obtaining internal alignment and established a repeatable process for future training initiatives.
A medical affairs team needed to engage a group of oncology and hematology specialists to gather insight on various topics around a rare type of cancer. In a pre-session webcast, the team maximized advisors' time by setting expectations prior to a two-week asynchronous advisory board, and then conducted a post-session webcast to review areas of consensus and collect final thoughts.
A medical affairs team needed insights on the use of a procedure among aestheticians in Mainland China and Taiwan. Within3 worked with the team to design a 10-day session with different question types to obtain quantitative and qualitative feedback. At the conclusion of the over-time session, the aestheticians participated in a live webcast to discuss the results of the advisory board.
A US-based commercial team within a global pharmaceutical company wanted to gather insight from physicians who specialize in treating a specific infectious disease. Within3 guided the team through a pre-session webcast to solidify objectives, followed by a week-long advisory board session to review resources and provide feedback.
A medical affairs team within a leading global life sciences company needed to establish a way to internally share posters, abstracts, and symposium recordings from medical congress events. Learn how Within3 helped the team set up a resource center to share information in a single, authoritative location.
A medical affairs team wanted to obtain feedback from physicians experienced in treating a type of neurological injury and a condition related to the injury. The team wanted to present details about a new therapy option – a portable medical device – to treat the related condition, then gather the physicians' thoughts on the new therapy.
A European medical affairs team wanted to obtain opinions and feedback on key study data presented at a medical congress. The team had already planned a face-to-face meeting with one group of oncologists, but wanted to solicit feedback from a different group of oncologists who normally would not have been included in the face-to-face meeting. The team used Within3 to conduct a virtual meeting with the second group and obtained robust insights within a short period of time.
A medical affairs team wanted to understand the level of impact the COVID-19 pandemic had on the treatment of patients with a chronic condition, in regards to both the availability of medical services and supplies as well as increased risk for the patients.
A medical affairs team based in Eastern Europe wanted to engage a group of physicians to better understand the ramifications of certain sleep disorders. Because it was impractical to conduct a live meeting due to a limited budget and the physicians' busy schedules, the team elected to hold a virtual, over-time meeting on the Within3 platform.
A medical affairs team within a leading pharmaceutical company wanted to gather patient perspectives about living with a chronic, but treatable, rare disease. The team used the Within3 virtual engagement platform to reach out to patients in the United States, Canada, and Europe – not all of whom would be able to travel or attend a webcast at the same time.
FYMCA Medical Ltd, a UK-based company that develops improved rare disease education and services for the developing world, wanted to identify problems impacting the care patients with rare diseases receive in resource-limited countries across Africa. The company formed a task force of rare disease clinicians and patient groups and used Within3 to hold a virtual session for the group to work toward its goals.
A medical affairs team wanted to capture physician feedback about information being presented at a medical congress. An on-site meeting would not be possible during the event, and the team decided to gather HCP insights using the Within3 virtual engagement platform.
A clinical team wanted to design a Phase III trial for a new therapy used to treat a rare disease. To gauge the economic viability of the new treatment, the team needed to understand how global payer organizations would weigh the benefits of the new therapy, and where the treatment might be placed in formularies. The team used Within3 to conduct a three-week, multi-part online advisory board meeting to efficiently gather input from payers around the world.
A medical affairs team within a leading pharmaceutical company wanted to identify unmet needs in the treatment of a specific type of cancer in the European patient population. They used a virtual engagement platform to eliminate scheduling conflicts and language barriers and achieve their objectives.
Following a successful patient recruitment period, a clinical operations team within a leading pharmaceutical company wanted to reduce the risk of patients deciding to prematurely discontinue participating in a clinical study.
A pharmaceutical company wanted timely feedback on physician-targeted messaging around a new drug delivery method. The company maintains a standing panel of experts accessible via the Within3 virtual engagement platform and was able to quickly call on a group of HCPs to provide input on the proposed messaging. The drug company also obtained critical information about treatment patterns and what types of patients might be considered for the new drug delivery mechanism.
Medical affairs teams attend medical congresses to record trends, collect impressions from KOLs, and communicate relevant information to other internal teams. The challenge is to record these insights in the moment without adding more meetings to an already busy schedule. In this customer success story, learn how a medical affairs team at a global pharmaceutical company used Within3’s virtual engagement platform to capture actionable insights onsite, extending the impact of an annual medical congress
Online discussion platforms improve business insights, enable more frequent customer touchpoints, and lower costs compared to traditional communication methods. Life sciences companies around the world are adding this capability across their enterprises to reduce costs, save time, and improve the overall quality of communication. In this success story, learn how a global pharmaceutical organization leveraged over-time meetings powered by an online discussion platform to save millions of dollars and generate 10x ROI in the first year alone.
A multibillion-dollar global pharmaceutical firm became frustrated with the time-consuming and labor-intensive publication process and wanted to improve it. To achieve its primary goals of finalizing a manuscript more quickly and improving the overall experience for authors, the company decided to use a co-authoring platform to shorten timelines, keep proprietary information secure, and give authors more flexibility to make more thoughtful and thorough contributions. In this success story, learn how a leading drug company leveraged co-authoring technology to simplify and expedite the manuscript development process.